CLINICAL_TRIALS
trial_result
· 2020-07-27
Clinical Trial Update: IMCgp100-401 Rollover Study [Phase 2]
Summary
Phase 2 rollover study for IMCgp100 in malignant melanoma was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immunocore Ltd | Conditions: Malignant Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-07-27